GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SUVPF) » Definitions » Net Income From Continuing Operations

SUVPF (Sartorius AG) Net Income From Continuing Operations : $202 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Sartorius AG Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sartorius AG's net income from continuing operations for the three months ended in Sep. 2024 was $34 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was $202 Mil.


Sartorius AG Net Income From Continuing Operations Historical Data

The historical data trend for Sartorius AG's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Net Income From Continuing Operations Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 336.65 516.72 755.25 1,251.80 420.83

Sartorius AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.07 31.63 79.46 56.94 34.18

Sartorius AG Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $202 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius AG Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG Headlines

From GuruFocus

Sartorius AG Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Nine Months 2019 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Sartorius AG Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Sartorius with clear double-digit growth in fiscal 2022

By PRNewswire PRNewswire 01-26-2023

Half Year 2019 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Sartorius AG Earnings Call Transcript

By GuruFocus Research 02-14-2024